Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study

Affiliations

• ¹ Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
• ² Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
• ³ Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
• ⁴ Department of Health Sciences, University of Genova, Genova, Italy.
• ⁵ Unit of Cellular Biology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
• ⁶ Intergruppo Melanoma Italiano (IMI) and Department of Internal Medicine, University of Genova, Genova, Italy.
• ⁷ Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy.
• ⁸ Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy.
• ⁹ Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy.
• ¹⁰ Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
• ¹¹ Department of Medical Oncology, Molecular Genetics Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II,"Bari, Italy.
• ¹² Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
• ¹³ Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
• ¹⁴ Immunotherapy and Cell Therapy, IRCCS-IRST, Meldola, Italy.